A.P. Gillett

554 total citations
22 papers, 463 citations indexed

About

A.P. Gillett is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, A.P. Gillett has authored 22 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Infectious Diseases and 5 papers in Molecular Medicine. Recurrent topics in A.P. Gillett's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotic Resistance in Bacteria (5 papers). A.P. Gillett is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotic Resistance in Bacteria (5 papers). A.P. Gillett collaborates with scholars based in United Kingdom, Mexico and Belize. A.P. Gillett's co-authors include Robert A. Wise, S.R. Durham, J. M. Andrews, R. Livingston, K. A. Bedford, M Webley, A. M. Geddes, D Grundy, J R Silver and V. Melikian and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

A.P. Gillett

21 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.P. Gillett United Kingdom 10 286 156 109 74 51 22 463
V. T. Lolans United States 8 314 1.1× 259 1.7× 167 1.5× 62 0.8× 63 1.2× 10 443
P. Schacht Germany 9 369 1.3× 123 0.8× 174 1.6× 47 0.6× 35 0.7× 15 550
P. J. Wilkinson United Kingdom 10 143 0.5× 99 0.6× 109 1.0× 99 1.3× 41 0.8× 16 353
Villy Frølund Thomsen Denmark 13 155 0.5× 144 0.9× 150 1.4× 111 1.5× 57 1.1× 30 557
Robert M. Lumish United States 8 116 0.4× 117 0.8× 137 1.3× 63 0.9× 74 1.5× 10 372
E.A.P. Croydon Australia 8 201 0.7× 65 0.4× 97 0.9× 83 1.1× 40 0.8× 12 399
G Tunevall Sweden 11 163 0.6× 115 0.7× 178 1.6× 95 1.3× 67 1.3× 37 506
D L Rotella United States 5 185 0.6× 98 0.6× 168 1.5× 109 1.5× 95 1.9× 10 352
R Hullmann Germany 5 243 0.8× 79 0.5× 159 1.5× 62 0.8× 28 0.5× 10 407
N. Galanakis Greece 10 122 0.4× 111 0.7× 170 1.6× 62 0.8× 30 0.6× 16 367

Countries citing papers authored by A.P. Gillett

Since Specialization
Citations

This map shows the geographic impact of A.P. Gillett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.P. Gillett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.P. Gillett more than expected).

Fields of papers citing papers by A.P. Gillett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.P. Gillett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.P. Gillett. The network helps show where A.P. Gillett may publish in the future.

Co-authorship network of co-authors of A.P. Gillett

This figure shows the co-authorship network connecting the top 25 collaborators of A.P. Gillett. A scholar is included among the top collaborators of A.P. Gillett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.P. Gillett. A.P. Gillett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ríos-Zertuche, Diego, et al.. (2023). Qualitative study of in-kind incentives to improve healthcare quality in Belize: Is quality work better than wealth?. PLoS ONE. 18(8). e0290457–e0290457.
2.
Gardner, B P, et al.. (1994). The prevention of spread of methicillin resistant Staphylococcus aureus in a spinal injuries centre. Spinal Cord. 32(11). 732–735. 14 indexed citations
3.
Gillett, A.P., et al.. (1987). Infective Cutaneous Gangrene—Urgency in Diagnosis and Treatment. Annals of Plastic Surgery. 19(3). 238–246. 9 indexed citations
4.
Gillett, A.P., et al.. (1985). Significance of antikeratin antibodies in rheumatoid arthritis.. PubMed. 12(1). 57–9. 23 indexed citations
5.
Gillett, A.P.. (1985). Antibiotic prophylaxis and therapy in burns. Journal of Hospital Infection. 6. 59–66. 9 indexed citations
6.
Gillett, A.P., et al.. (1984). Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice.. PubMed. 34(262). 255–7. 7 indexed citations
7.
Gillett, A.P.. (1982). Microbiology in clinical practice. Journal of Hospital Infection. 3(4). 404–404. 10 indexed citations
8.
Gillett, A.P.. (1981). Production of sterile fluids in hospital pharmacies. Journal of Hospital Infection. 2(2). 113–115. 2 indexed citations
9.
Wise, Robert A., A.P. Gillett, J. M. Andrews, & K. A. Bedford. (1980). Ro 13–9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an in vitro comparative study. Journal of Antimicrobial Chemotherapy. 6(5). 595–600. 32 indexed citations
10.
Wise, Robert A., et al.. (1980). The Influence of Protein Binding upon Tissue Fluid Levels of Six  -Lactam Antibiotics. The Journal of Infectious Diseases. 142(1). 77–82. 130 indexed citations
11.
Wise, Robert A., A.P. Gillett, & J. M. Andrews. (1979). The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid. Journal of Antimicrobial Chemotherapy. 5(3). 301–306. 7 indexed citations
12.
Wise, Robert A., et al.. (1979). The pharmacology of cefoxitin and the comparison of two human tissue models. Journal of Infection. 1. 49–56. 8 indexed citations
13.
Ball, A. P., I. D. Farrell, A.P. Gillett, et al.. (1979). Enteric fever in Birmingham: Clinical features, laboratory investigation and comparison of treatment with pivmecillinam and co-trimoxazole. Journal of Infection. 1(4). 353–365. 8 indexed citations
14.
Wise, Robert A., A.P. Gillett, A Bhamjee, et al.. (1979). Pharmacokinetics of Bay k 4999, a New Broad-Spectrum Penicillin. Antimicrobial Agents and Chemotherapy. 15(5). 670–673. 2 indexed citations
15.
Gillett, A.P., Robert I. Wise, & A. M. Geddes. (1978). Use of antibiotics. Infection in the compromised host.. BMJ. 2(6133). 335–337. 2 indexed citations
16.
Wise, Robert A., et al.. (1978). PROTEIN BINDING AND ANTIBIOTIC CONCENTRATIONS. The Lancet. 312(8086). 431–431. 2 indexed citations
17.
Wise, Robert A., A.P. Gillett, J. M. Andrews, & K. A. Bedford. (1978). Activity of Azlocillin and Mezlocillin Against Gram-Negative Organisms: Comparison with Other Penicillins. Antimicrobial Agents and Chemotherapy. 13(4). 559–565. 49 indexed citations
18.
Falk, Rodney H., A.P. Gillett, Robert A. Wise, & V. Melikian. (1977). Tobramycin and clindamycin in the treatment of febrile leukaemic patients. Journal of Antimicrobial Chemotherapy. 3(4). 317–322. 2 indexed citations
19.
Gillett, A.P., Rodney H. Falk, J. M. Andrews, Robert A. Wise, & V. Melikian. (1976). Rapid Intravenous Injection of Tobramycin: Suggested Dosage Schedule and Concentrations in Serum. The Journal of Infectious Diseases. 134(Supplement 1). S110–S113. 16 indexed citations
20.
Geddes, A. M., et al.. (1974). Clinical and Laboratory Studies with Tobramycin. Chemotherapy. 20(4). 245–256. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026